TuHURA Biosciences (HURA) Payables (2011 - 2026)

TuHURA Biosciences' Payables history runs 16 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• On a quarterly basis, Payables rose 28.21% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 28.21% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, down 27.08% from the prior year.
• Payables climbed to $4.0 million in Q1 2026 per HURA's latest filing, from $3.8 million in the prior quarter.
• Across five years, Payables topped out at $12.5 million in Q2 2025 and bottomed at $1.2 million in Q1 2024.
• The 5-year median for Payables is $3.0 million (2023), against an average of $3.7 million.
• Across the five-year window, Payables slumped 52.38% in 2024 and surged 467.61% in 2025, its largest moves.
• Year by year, Payables stood at $2.7 million in 2022, then jumped by 32.87% to $3.6 million in 2023, then jumped by 44.6% to $5.2 million in 2024, then decreased by 27.08% to $3.8 million in 2025, then grew by 4.88% to $4.0 million in 2026.
• Per Business Quant, the three latest HURA Payables figures stand at $4.0 million (Q1 2026), $3.8 million (Q4 2025), and $6.0 million (Q3 2025).